We have collected information about Recent Perspectives In Ocular Drug Delivery for you. Follow the links to find out details on Recent Perspectives In Ocular Drug Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516219/
Recent Perspectives in Ocular Drug Delivery Ripal Gaudana , 1 J. Jwala , 1 Sai H. S. Boddu , 1 and Ashim K. Mitra 1, 2 1 Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USAAuthor: Ripal Gaudana, J. Jwala, Sai H. S. Boddu, Ashim K. Mitra
https://link.springer.com/article/10.1007%2Fs11095-008-9694-0
Aug 29, 2008 · Ocular drug delivery has remained as one of the most challenging task for pharmaceutical scientists. The unique structure of the eye restricts the entry of drug molecules at the required site of action. Drug delivery to the eye can be broadly classified into anterior and posterior segments (Fig. 1).Author: Ripal Gaudana, J. Jwala, Sai H. S. Boddu, Ashim K. Mitra
https://www.researchgate.net/publication/23225248_Recent_Perspectives_in_Ocular_Drug_Delivery
Compared with other parts of the body, ocular drug delivery has remained one of the most challenging tasks for a pharmaceutical sci- entist. The unique anatomy and physiology of the eye make it highly protected and, thus, limits the entry of drug molecules to the site of action [1][2][3].
https://paperity.org/p/12132736/recent-perspectives-in-ocular-drug-delivery
Ocular drug delivery—eye on innovation Ocular drug delivery—eye on innovation. Functional intercalated nanocomposites with chitosan-glutathione... Functional intercalated nanocomposites with chitosan-glutathione-glycylsarcosine and layered double hydroxides for topical ocular drug delivery. Critical Assessment of Implantable Drug Delivery Devices in Glaucoma Management Critical Assessment of Implantable Drug Delivery Devices …Author: Ripal Gaudana, J. Jwala, Sai H. S. Boddu, Ashim K. Mitra
https://www.deepdyve.com/lp/springer-journals/recent-perspectives-in-ocular-drug-delivery-5Ub3hwDdO0
Aug 29, 2008 · Recent Perspectives in Ocular Drug Delivery Designing an effective therapy for ocular diseases, especially for the posterior segment, has been considered as a formidable task. Limitations of topical and intravitreal route of administration have challenged scientists to find alternative mode of administration like periocular routes.
https://www.liebertpub.com/doi/10.1089/jop.1986.2.67
Undoubtedly, interest in the broad area of ocular drug delivery has increased in recent years due to an increased understanding of a number of ocular physiological processes and pathological conditions, including aqueous humor dynamics, inflammation, corneal wound healing, and cataractogenesis, with a parallel increase in the number of drugs and drug candidates that have a beneficial effect in …Author: Vincent H.L. Lee, Joseph R. Robinson
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570518/
In this review, we have described the recent perspectives on the delivery of biologics to ocular tissues with special emphasis to back-of-the-eye tissues (retina-choroid). Moreover, we have also discussed barriers to ocular delivery of macromolecules and strategies to overcome such barriers.Author: Mary Joseph, Hoang M. Trinh, Kishore Cholkar, Dhananjay Pal, Ashim K. Mitra
https://www.sciencedirect.com/science/article/pii/S1350946297000025
The behaviour of liposomes as an ocular drug delivery system has been observed to be, in part, due to surface charge. Positively charged 44 C. Le Bourlais et al. liposomes seemed to be preferentially captured at the negatively charged corneal surface as compared with …Author: Chrystèle Le Bourlais, Liliane Acar, Hosein Zia, Pierre A. Sado, Thomas Needham, Roger Leverge
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-018-0392-8
Sep 19, 2018 · Polymeric micelles are reported to be applicable for both drug delivery against cancer and also for ocular drug delivery as shown in Fig. 3 in which a polymeric micelle is used for reaching the posterior ocular tissues .Author: Jayanta Kumar Patra, Gitishree Das, Leonardo Fernandes Fraceto, Leonardo Fernandes Fraceto, Estefani...
https://www.tandfonline.com/doi/abs/10.1080/17425247.2016.1227783
Sep 01, 2016 · Nanotechnology-based delivery systems, like drug encapsulation technology, macromolecule implants and gene delivery are under investigation. We provide an overview of emerging technologies for biologics delivery to back of the eye tissues. Moreover, new biologic drugs currently in clinical trials for ocular neovascular diseases have been discussed.Author: Mary Joseph, Hoang M. Trinh, Kishore Cholkar, Dhananjay Pal, Ashim K. Mitra
Searching for Recent Perspectives In Ocular Drug Delivery?
You can just click the links above. The data is collected for you.
